VDAC1 in the diseased myocardium and the effect of VDAC1-interacting compound on atrial fibrosis induced by hyperaldosteronism

Abstract The voltage-dependent anion channel 1 (VDAC1) is a key player in mitochondrial function. VDAC1 serves as a gatekeeper mediating the fluxes of ions, nucleotides, and other metabolites across the outer mitochondrial membrane, as well as the release of apoptogenic proteins initiating apoptotic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hadar Klapper-Goldstein, Ankit Verma, Sigal Elyagon, Roni Gillis, Michael Murninkas, Srinivas Pittala, Avijit Paul, Varda Shoshan-Barmatz, Yoram Etzion
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/fe4f01af963c46d29e0a0168157ce1cc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fe4f01af963c46d29e0a0168157ce1cc
record_format dspace
spelling oai:doaj.org-article:fe4f01af963c46d29e0a0168157ce1cc2021-12-02T12:42:18ZVDAC1 in the diseased myocardium and the effect of VDAC1-interacting compound on atrial fibrosis induced by hyperaldosteronism10.1038/s41598-020-79056-w2045-2322https://doaj.org/article/fe4f01af963c46d29e0a0168157ce1cc2020-12-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-79056-whttps://doaj.org/toc/2045-2322Abstract The voltage-dependent anion channel 1 (VDAC1) is a key player in mitochondrial function. VDAC1 serves as a gatekeeper mediating the fluxes of ions, nucleotides, and other metabolites across the outer mitochondrial membrane, as well as the release of apoptogenic proteins initiating apoptotic cell death. VBIT-4, a VDAC1 oligomerization inhibitor, was recently shown to prevent mitochondrial dysfunction and apoptosis, as validated in mouse models of lupus and type-2 diabetes. In the present study, we explored the expression of VDAC1 in the diseased myocardium of humans and rats. In addition, we evaluated the effect of VBIT-4 treatment on the atrial structural and electrical remodeling of rats exposed to excessive aldosterone levels. Immunohistochemical analysis of commercially available human cardiac tissues revealed marked overexpression of VDAC1 in post-myocardial infarction patients, as well as in patients with chronic ventricular dilatation\dysfunction. In agreement, rats exposed to myocardial infarction or to excessive aldosterone had a marked increase of VDAC1 in both ventricular and atrial tissues. Immunofluorescence staining indicated a punctuated appearance typical for mitochondrial-localized VDAC1. Finally, VBIT-4 treatment attenuated the atrial fibrotic load of rats exposed to excessive aldosterone without a notable effect on the susceptibility to atrial fibrillation episodes induced by burst pacing. Our results indicate that VDAC1 overexpression is associated with myocardial abnormalities in common pathological settings. Our data also indicate that inhibition of the VDAC1 can reduce excessive fibrosis in the atrial myocardium, a finding which may have important therapeutic implications. The exact mechanism\s of this beneficial effect need further studies.Hadar Klapper-GoldsteinAnkit VermaSigal ElyagonRoni GillisMichael MurninkasSrinivas PittalaAvijit PaulVarda Shoshan-BarmatzYoram EtzionNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-16 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Hadar Klapper-Goldstein
Ankit Verma
Sigal Elyagon
Roni Gillis
Michael Murninkas
Srinivas Pittala
Avijit Paul
Varda Shoshan-Barmatz
Yoram Etzion
VDAC1 in the diseased myocardium and the effect of VDAC1-interacting compound on atrial fibrosis induced by hyperaldosteronism
description Abstract The voltage-dependent anion channel 1 (VDAC1) is a key player in mitochondrial function. VDAC1 serves as a gatekeeper mediating the fluxes of ions, nucleotides, and other metabolites across the outer mitochondrial membrane, as well as the release of apoptogenic proteins initiating apoptotic cell death. VBIT-4, a VDAC1 oligomerization inhibitor, was recently shown to prevent mitochondrial dysfunction and apoptosis, as validated in mouse models of lupus and type-2 diabetes. In the present study, we explored the expression of VDAC1 in the diseased myocardium of humans and rats. In addition, we evaluated the effect of VBIT-4 treatment on the atrial structural and electrical remodeling of rats exposed to excessive aldosterone levels. Immunohistochemical analysis of commercially available human cardiac tissues revealed marked overexpression of VDAC1 in post-myocardial infarction patients, as well as in patients with chronic ventricular dilatation\dysfunction. In agreement, rats exposed to myocardial infarction or to excessive aldosterone had a marked increase of VDAC1 in both ventricular and atrial tissues. Immunofluorescence staining indicated a punctuated appearance typical for mitochondrial-localized VDAC1. Finally, VBIT-4 treatment attenuated the atrial fibrotic load of rats exposed to excessive aldosterone without a notable effect on the susceptibility to atrial fibrillation episodes induced by burst pacing. Our results indicate that VDAC1 overexpression is associated with myocardial abnormalities in common pathological settings. Our data also indicate that inhibition of the VDAC1 can reduce excessive fibrosis in the atrial myocardium, a finding which may have important therapeutic implications. The exact mechanism\s of this beneficial effect need further studies.
format article
author Hadar Klapper-Goldstein
Ankit Verma
Sigal Elyagon
Roni Gillis
Michael Murninkas
Srinivas Pittala
Avijit Paul
Varda Shoshan-Barmatz
Yoram Etzion
author_facet Hadar Klapper-Goldstein
Ankit Verma
Sigal Elyagon
Roni Gillis
Michael Murninkas
Srinivas Pittala
Avijit Paul
Varda Shoshan-Barmatz
Yoram Etzion
author_sort Hadar Klapper-Goldstein
title VDAC1 in the diseased myocardium and the effect of VDAC1-interacting compound on atrial fibrosis induced by hyperaldosteronism
title_short VDAC1 in the diseased myocardium and the effect of VDAC1-interacting compound on atrial fibrosis induced by hyperaldosteronism
title_full VDAC1 in the diseased myocardium and the effect of VDAC1-interacting compound on atrial fibrosis induced by hyperaldosteronism
title_fullStr VDAC1 in the diseased myocardium and the effect of VDAC1-interacting compound on atrial fibrosis induced by hyperaldosteronism
title_full_unstemmed VDAC1 in the diseased myocardium and the effect of VDAC1-interacting compound on atrial fibrosis induced by hyperaldosteronism
title_sort vdac1 in the diseased myocardium and the effect of vdac1-interacting compound on atrial fibrosis induced by hyperaldosteronism
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/fe4f01af963c46d29e0a0168157ce1cc
work_keys_str_mv AT hadarklappergoldstein vdac1inthediseasedmyocardiumandtheeffectofvdac1interactingcompoundonatrialfibrosisinducedbyhyperaldosteronism
AT ankitverma vdac1inthediseasedmyocardiumandtheeffectofvdac1interactingcompoundonatrialfibrosisinducedbyhyperaldosteronism
AT sigalelyagon vdac1inthediseasedmyocardiumandtheeffectofvdac1interactingcompoundonatrialfibrosisinducedbyhyperaldosteronism
AT ronigillis vdac1inthediseasedmyocardiumandtheeffectofvdac1interactingcompoundonatrialfibrosisinducedbyhyperaldosteronism
AT michaelmurninkas vdac1inthediseasedmyocardiumandtheeffectofvdac1interactingcompoundonatrialfibrosisinducedbyhyperaldosteronism
AT srinivaspittala vdac1inthediseasedmyocardiumandtheeffectofvdac1interactingcompoundonatrialfibrosisinducedbyhyperaldosteronism
AT avijitpaul vdac1inthediseasedmyocardiumandtheeffectofvdac1interactingcompoundonatrialfibrosisinducedbyhyperaldosteronism
AT vardashoshanbarmatz vdac1inthediseasedmyocardiumandtheeffectofvdac1interactingcompoundonatrialfibrosisinducedbyhyperaldosteronism
AT yorametzion vdac1inthediseasedmyocardiumandtheeffectofvdac1interactingcompoundonatrialfibrosisinducedbyhyperaldosteronism
_version_ 1718393720388190208